罕见PTGIS变异与特发性肺动脉高压易感性及肺血管反应性的关联
该两阶段病例对照遗传关联研究纳入230例无BMPR2变异的特发性肺动脉高压患者和968例健康对照,发现PTGIS罕见变异在病例中富集(6.1% vs 0.8%,OR 7.8),且携带者吸入伊洛前列素后肺血管阻力下降和心脏指数增加更显著,提示PTGIS变异参与IPAH发病及肺血管反应。
要点
- PTGIS罕见变异与IPAH易感性显著相关(OR 7.8,95%CI 3.2-18.8)。
- 携带PTGIS变异的IPAH患者对吸入伊洛前列素的肺血管反应更佳。
- PTGIS功能缺失变异可能通过降低前列环素生成参与IPAH发病。
核心结论
- 在无BMPR2变异的IPAH患者中鉴定出3个PTGIS基因罕见功能缺失变异,这些变异与IPAH易感性及肺血管对伊洛前列素的反应相关。
研究设计与样本
- 两阶段病例对照遗传关联研究,纳入中国2个转诊中心的230例无BMPR2变异的IPAH患者和968例健康对照,进行全基因组测序及独立队列验证。
主要发现
- 合并数据中PTGIS罕见变异见于14/230例病例(6.1%)和8/968例对照(0.8%),OR 7.8(95%CI 3.2-18.8),P=5×10^-6。
- 微小基因实验显示c.521+1G>A变异导致异常mRNA转录本;两个错义变异(R252Q和A447T)降低前列环素生成并增加肺微血管内皮细胞死亡。
临床怎么用
- 对于无BMPR2变异的IPAH患者,可考虑检测PTGIS罕见变异以辅助评估对吸入伊洛前列素的肺血管反应性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Idiopathic pulmonary arterial hypertension (IPAH) is a fatal disease with high heritability; however, the bone morphogenetic protein receptor 2 (BMPR2) gene only accounts for 17% of IPAH. The genetic basis of IPAH needs further investigation. OBJECTIVE: To identify novel IPAH susceptibility genes other than BMPR2. DESIGN, SETTING, AND PARTICIPANTS: This 2-stage, case-control genetic association study enrolled 230 patients with IPAH from 2 referral pulmonary hypertension centers in China. Eligible patients had no BMPR2 variants and were compared with 968 healthy control participants. Data were collected from January 1, 2000, to July 31, 2015, and analyzed from August 1, 2015, to May 30, 2018. EXPOSURES: PTGIS rare variants. MAIN OUTCOMES AND MEASURES: Whole-genome sequencing was performed to identify putative IPAH genes in a discovery cohort, with validation in an independent referral cohort. Correlation of genotype and hemodynamic characteristics was then evaluated at baseline and after pulmonary vasodilator testing. Functional assessments were conducted to analyze the effects of identified genetic variants on transcript splicing, enzymatic activity, and endothelial cell phenotypes. RESULTS: Among 230 patients with IPAH (164 female [71.3%]; mean [SD] age, 34 [18] years), an enrichment of rare variants in a gene encoding prostacyclin synthase (PTGIS) was identified in the discovery cohort. The association of PTGIS rare variants with IPAH was confirmed in the replication cohort. In the combined data set, PTGIS rare variants were found in 14 of 230 cases (6.1%) and 8 of 968 controls (0.8%) (odds ratio, 7.8; 95% CI, 3.2-18.8; P = 5 × 10-6, logistic regression). Compared with patients without PTGIS variants, inhaled iloprost induced a more significant decrease of pulmonary vascular resistance (difference in the least square mean, -21.7%; 95% CI, -31.4% to -12.0%; P < .001, linear regression model) and an increase of cardiac index (difference in the least square mean, 18.3%; 95% CI, 8.8%-27.8%; P < .001, linear regression model) in patients with PTGIS variants. The minigene assay indicated that the c.521 + 1G>A variant resulted in aberrant messenger RNA transcripts. The functional studies showed that the 2 missense rare variants (R252Q and A447T) resulted in a decrease in prostacyclin production and increased cell death of pulmonary microvascular endothelial cells. CONCLUSIONS AND RELEVANCE: This study identified 3 rare loss-of-function variants in the PTGIS gene from 2 independent cohorts with IPAH. The genetic variants of PTGIS predispose pulmonary vascular responses to the iloprost stimulation. These findings suggest that PTGIS variants may be involved in the pathogenesis of IPAH.
引用
- Wang XJ, Xu XQ, Sun K, et al. Association of Rare PTGIS Variants With Susceptibility and Pulmonary Vascular Response in Patients With Idiopathic Pulmonary Arterial Hypertension. JAMA Cardiol. 2020. PMID: 32236489. doi:10.1001/jamacardio.2020.0479
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。